Peter C. Wever

5.8k total citations · 1 hit paper
129 papers, 3.8k citations indexed

About

Peter C. Wever is a scholar working on Parasitology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Peter C. Wever has authored 129 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Parasitology, 43 papers in Epidemiology and 41 papers in Infectious Diseases. Recurrent topics in Peter C. Wever's work include Vector-borne infectious diseases (59 papers), Viral Infections and Vectors (27 papers) and Mosquito-borne diseases and control (23 papers). Peter C. Wever is often cited by papers focused on Vector-borne infectious diseases (59 papers), Viral Infections and Vectors (27 papers) and Mosquito-borne diseases and control (23 papers). Peter C. Wever collaborates with scholars based in Netherlands, Germany and United States. Peter C. Wever's co-authors include Tom van der Poll, Peter M. Schneeberger, Mirjam H. A. Hermans, Jacqueline de Jongh-Leuvenink, Cornelis P. C. de Jager, Rejiv B. Mathoera, Alexander C. A. P. Leenders, Nicole H. M. Renders, Ron Kusters and Linda M. Kampschreur and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Peter C. Wever

127 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit

2010 499 citations Peter C. Wever et al. profile →

Peers

Countries citing papers authored by Peter C. Wever

Since Specialization

Citations

This map shows the geographic impact of Peter C. Wever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Wever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Wever more than expected).

Fields of papers citing papers by Peter C. Wever

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Wever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Wever. The network helps show where Peter C. Wever may publish in the future.

Co-authorship network of co-authors of Peter C. Wever

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Wever. A scholar is included among the top collaborators of Peter C. Wever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Wever. Peter C. Wever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unveiling the Spectrum of Respiratory Syncytial Virus Disease in Adults: From Community to Hospital 2025 ·Influenza and Other Respiratory Viruses ·Koos Korsten, Matthijs R. A. Welkers, Thijs van de Laar, Alex Wagemakers, Peter van Hengel, Peter C. Wever, Eva Kolwijck	2
2	An outbreak of Pseudomonas aeruginosa urinary tract infections following cystoscopy traceable to a malfunctioning drying cabinet 2024 ·Infection Prevention in Practice ·(unknown), (unknown), (unknown), (unknown), (unknown), Mirjam H. A. Hermans, (unknown), Peter C. Wever	1
3	Using the Sysmex UF‐4000 urine flow cytometer for rapid diagnosis of urinary tract infection in the clinical microbiological laboratory 2024 ·Journal of Clinical Laboratory Analysis ·Koos Korsten, (unknown), Alexander C. A. P. Leenders, Peter C. Wever, Eva Kolwijck	3
4	Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave 2022 ·Journal of Fungi ·Robbert G. Bentvelsen, Andreas van Arkel, Tom A. Rijpstra, (unknown), Simone van der Sar–van der Brugge, Daan W. Loth, Peter van Wijngaarden, (unknown), (unknown), B. M. W. Diederen, Peter C. Wever, Alexander C. A. P. Leenders, (unknown), (unknown), Wouter van den Bijllaardt, Paul E. Verweij	9
5	No increased risk of mature B-cell non-Hodgkin lymphoma after Q fever detected: results from a 16-year ecological analysis of the Dutch population incorporating the 2007–2010 Q fever outbreak 2022 ·International Journal of Epidemiology ·Jesper M. Weehuizen, (unknown), (unknown), Wim van der Hoek, Marc J. M. Bonten, Andy I. M. Hoepelman, Chantal P. Bleeker‐Rovers, Peter C. Wever, Jan Jelrik Oosterheert	5
6	No Influence of Previous Coxiella burnetii Infection on ICU Admission and Mortality in Emergency Department Patients Infected with SARS-CoV-2 2022 ·Journal of Clinical Medicine ·Jesper M. Weehuizen, (unknown), Andy I. M. Hoepelman, Chantal P. Bleeker‐Rovers, Jan Jelrik Oosterheert, Peter C. Wever	1
7	Identified micro-organisms in hospitalized community-acquired pneumonia patients living near goat and poultry farms 2021 ·SHILAP Revista de lepidopterología ·(unknown), Arianne B. van Gageldonk‐Lafeber, Tizza P. Zomer, (unknown), Peter C. Wever, Wim van der Hoek	0
8	Long-term serological follow-up after primary Coxiella burnetii infection in patients with vascular risk factors for chronic Q fever 2021 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), (unknown), Jan Jelrik Oosterheert, (unknown), Andy I. M. Hoepelman, Nicole H. M. Renders, A.S. van Petersen, Chantal P. Bleeker‐Rovers, Peter C. Wever, Olivier H.J. Koning	3
9	Genetic variations in innate immunity genes affect response to Coxiella burnetii and are associated with susceptibility to chronic Q fever 2019 ·Clinical Microbiology and Infection ·Anne F.M. Jansen, Teske Schoffelen, Chantal P. Bleeker‐Rovers, Peter C. Wever, Martin Jaeger, Marije Oosting, (unknown), Leo A. B. Joosten, Mihai G. Netea, Marcel van Deuren, Esther van de Vosse	13
10	The value of the neutrophil-lymphocyte count ratio in the diagnosis of sepsis in patients admitted to the Intensive Care Unit: A retrospective cohort study 2019 ·PLoS ONE ·(unknown), Koen S. Simons, (unknown), Peter C. Wever, Peter Pickkers, Cornelis P. C. de Jager	39
11	Coxiella burnetii in non-Hodgkin lymphoma tissue samples: Innocent until proven otherwise? 2018 ·Immunobiology ·(unknown), Mirjam H. A. Hermans, Peet Nooijen, A H E Herbers, Chantal P. Bleeker‐Rovers, Andy I. M. Hoepelman, Jan Jelrik Oosterheert, Peter C. Wever	8
12	Chronic Q fever: patient and treatment-related factors influencing long-term quality of life 2018 ·QJM ·(unknown), (unknown), Cornelia H.M. van Jaarsveld, Linda M. Kampschreur, (unknown), Peter C. Wever, Chantal P. Bleeker‐Rovers, Jan Jelrik Oosterheert	7
13	Chronic Q fever-related complications and mortality: data from a nationwide cohort 2018 ·Clinical Microbiology and Infection ·(unknown), Peter C. Wever, Linda M. Kampschreur, P Gruteke, Wim van der Hoek, Andy I. M. Hoepelman, Chantal P. Bleeker‐Rovers, Jan Jelrik Oosterheert	42
14	Primary and secondary arterial fistulas during chronic Q fever 2018 ·Journal of Vascular Surgery ·(unknown), (unknown), Jan Jelrik Oosterheert, Chantal P. Bleeker‐Rovers, Nicole H. M. Renders, Gert J. de Borst, Linda M. Kampschreur, Andy I. M. Hoepelman, Olivier H.J. Koning, Peter C. Wever	12
15	Exposure to Coxiella burnetii and risk of non-Hodgkin lymphoma: a retrospective population-based analysis in the Netherlands 2018 ·The Lancet Haematology ·(unknown), (unknown), (unknown), (unknown), (unknown), Wim van der Hoek, Linda M. Kampschreur, Marc J. M. Bonten, Andy I. M. Hoepelman, Chantal P. Bleeker‐Rovers, Peter C. Wever, Jan Jelrik Oosterheert	16
16	High pneumococcal DNA load, procalcitonin and suPAR levels correlate to severe disease development in patients with pneumococcal pneumonia 2017 ·European Journal of Clinical Microbiology & Infectious Diseases ·Anne J. M. Loonen, (unknown), Ron Kusters, Mirrian Hilbink, Peter C. Wever, Adriaan J. C. van den Brule	17
17	Characteristics of Hospitalized Acute Q Fever Patients during a Large Epidemic, The Netherlands 2014 ·PLoS ONE ·Cornelia C. H. Wielders, (unknown), (unknown), (unknown), (unknown), Frederika Dijkstra, Arianne B. van Gageldonk‐Lafeber, Jeroen P. G. van Leuken, Peter C. Wever, Wim van der Hoek, Peter M. Schneeberger	27
18	Prevention of tetanus during the First World War 2012 ·Journal of Medical Humanities ·Leo van Bergen, Peter C. Wever	1
19	Evaluation of a Diagnostic Algorithm for Acute Q Fever in an Outbreak Setting 2011 ·Clinical and Vaccine Immunology ·(unknown), G. Weers-Pothoff, Mirjam H. A. Hermans, J. Meekelenkamp, Jeroen J. A. Schellekens, Nicole H. M. Renders, Alexander C. A. P. Leenders, Peter M. Schneeberger, Peter C. Wever	25
20	Epiglottitis in the adult patient. 2008 ·PubMed ·(unknown), Peter C. Wever, (unknown), (unknown), Cornelis P. C. de Jager	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact